Diligence teams must identify every in-license with an anti-assignment or change-of-control clause and, for each, assess the competitive relationship between the acquirer and the licensor
note that tirzepatide is also available as Mounjaro, which holds a separate MHRA authorisation for the treatment of type 2 diabetes these are distinct licensed indications and should not be confused [14] [15] These medicines are supported by robust clinical trial data, have established safety profiles, and are prescribed within regulated frameworks with appropriate monitoring
H.AnsariA
The balance between ROS production and antioxidant responses, as well as the cellular context, determines the impact of ROS on necroptosis and the subsequent cellular outcome
Xu S, Li S, Yang Y, Tan J, Lou H, Jin W, Yang L, Pan X, Wang J, Shen Y, Wu B